EnPro Inc. 10-Q Summary: Quarter Ended March 31, 2010
Business Context and Reporting Period
This filing covers the quarterly period ended March 31, 2010, for EnPro Industries, Inc., a manufacturer of engineered industrial products including sealing products, bearings, and reciprocating engines. The company operates through three segments: Sealing Products, Engineered Products, and Engine Products and Services. A significant event during the period was the completion of the sale of the Quincy Compressor business on March 1, 2010, which is reported as a discontinued operation.
Key Financial Metrics
| Metric | Q1 2010 | Q1 2009 |
|---|---|---|
| Net Sales (Continuing) | $228.2 million | $185.1 million |
| Gross Profit | $88.6 million | $64.2 million |
| Operating Income (Continuing) | $11.1 million | $(8.2) million |
| Net Income (Total) | $99.0 million | $3.2 million |
| Diluted EPS (Total) | $4.83 | $0.16 |
| Cash and Equivalents (End of Period) | $253.8 million | $56.3 million |
| Long-Term Debt | $131.6 million | $130.3 million |
| Asbestos Liability (Total) | $477.8 million | $465.8 million |
Note: Net income for Q1 2010 includes a $93.4 million gain from discontinued operations (sale of Quincy Compressor). Net income from continuing operations was $5.6 million.
Material Changes vs. Prior Period
- Revenue Growth: Net sales from continuing operations increased 23% to $228.2 million, driven by stronger volumes across all segments, favorable foreign currency exchange rates, and contributions from recent acquisitions.
- Profitability: Operating income from continuing operations turned positive ($11.1 million) compared to a loss of $8.2 million in the prior year. Segment profit increased 161% to $34.2 million, with margins improving from 7.1% to 15.0%.
- Discontinued Operations: The sale of Quincy Compressor generated $184.2 million in cash proceeds and a net gain of $91.9 million, significantly boosting total net income and cash balances.
- Asbestos Expenses: Asbestos-related expenses increased slightly to $14.5 million from $13.6 million. Net cash outflows for asbestos claims increased to $16.4 million due to higher settlement payments, partially offset by increased insurance recoveries.
Guidance, Outlook, and Risks
Outlook: Management expects demand to continue recovering in the second half of 2010. The company anticipates a lower effective tax rate in 2010 due to structural changes in European operations. Cash flows are expected to benefit from improved operating income, though offset by higher capital expenditures and pension contributions.
Asbestos Contingencies: The company faces significant uncertainty regarding asbestos litigation. The recorded liability for the next ten years is estimated at $468 million (plus accrued fees). Management notes that while total payments may decline, net cash outflows (after insurance) could increase significantly starting in 2011 as insurance coverage diminishes. There is a risk that future expenditures could exceed $1 billion.
Other Risks: The company is subject to environmental remediation costs at 17 sites and contingent liabilities related to divested businesses (Colt Firearms, Central Moloney, and Crucible Materials Corporation).
Investor Verification Checklist
- Discontinued Operations Impact: Verify the sustainability of earnings by analyzing results excluding the one-time $91.9 million gain from the Quincy Compressor sale.
- Asbestos Liability Accuracy: Review the assumptions used in the Bates White liability estimate and the quality of the remaining $219.4 million in insurance coverage, noting the risk of increased net cash outflows post-2010.
- Segment Margin Sustainability: Assess whether the 15.0% segment margin is sustainable given the mix of aftermarket sales and potential raw material cost fluctuations.
- Liquidity Position: Confirm the availability of the $63.8 million senior secured revolving credit facility and the company's ability to fund future pension contributions ($3.4 million expected in 2010).
- Convertible Debt: Monitor the stock price relative to the $33.79 conversion price of the $172.5 million convertible debentures to assess potential dilution risks.